Presentation Open Access

HDSA Convention Presentation: From proteins to people: understanding Huntington's disease at the molecular level

Harding, Rachel


BibTeX Export

@misc{harding_rachel_2019_3383392,
  author       = {Harding, Rachel},
  title        = {{HDSA Convention Presentation: From proteins to 
                   people: understanding Huntington's disease at the
                   molecular level}},
  month        = jun,
  year         = 2019,
  note         = {{Dr. Harding is the recipient of the Huntington's 
                   Disease Society of America Berman Topper Career
                   Development Fellowship which funds and supports
                   this research, in addition to generous funding
                   from the CHDI Foundation and the Huntington
                   Society of Canada. The SGC is a registered charity
                   (number 1097737) that receives funds from AbbVie,
                   Bayer Pharma AG, Boehringer Ingelheim, Canada
                   Foundation for Innovation, Eshelman Institute for
                   Innovation, Genome Canada through Ontario Genomics
                   Institute [OGI-055], Innovative Medicines
                   Initiative (EU/EFPIA) [ULTRA-DD grant no. 115766],
                   Janssen, Merck KGaA, Darmstadt, Germany, MSD,
                   Novartis Pharma AG, Ontario Ministry of Research,
                   Innovation and Science (MRIS), Pfizer, São Paulo
                   Research Foundation-FAPESP, Takeda, and Wellcome.}},
  publisher    = {Zenodo},
  doi          = {10.5281/zenodo.3383392},
  url          = {https://doi.org/10.5281/zenodo.3383392}
}
87
163
views
downloads
All versions This version
Views 8787
Downloads 163163
Data volume 4.8 GB4.8 GB
Unique views 8080
Unique downloads 158158

Share

Cite as